Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy

Circ Genom Precis Med. 2024 Apr;17(2):e004353. doi: 10.1161/CIRCGEN.123.004353. Epub 2024 Feb 15.

Affiliations

¹ Cardiology Unit (E.B., G.C., S.F., F.G., A.G., G.S., S.P., I.O.), Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy.
² Oncology Division (A. Tamburini, A. Tondo), Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy.

PMID: 38357805
DOI: 10.1161/CIRCGEN.123.004353

No abstract available

Keywords: cardiomyopathies; cardiotoxicity; genetics; high-throughput nucleotide sequencing; retrospective studies.

Publication types

Letter

MeSH terms

Cardiomyopathies* / diagnosis
Cardiomyopathies* / genetics
Child
Genetic Testing
Humans
Ventricular Dysfunction, Left* / diagnosis
Ventricular Dysfunction, Left* / genetics